Insider Trading History of Schafer Gregory W

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Schafer Gregory W since 2006. The trader's CIK number is 1193195. At the time of the last reporting, Schafer Gregory W was the Director of Aduro Biotech, Inc.. (stock ticker symbol ADRO). Also see all insider trading activities at Aduro Biotech, Inc..

Note that in the past SCHAFER GREGORY W also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Aduro Biotech, Inc. (ADRO) by Schafer Gregory W

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2018 ADRO 0 $0 20,000 $152,140 122,000 $106,340
2017 ADRO 0 $0 164,859 $1,785,955 160,000 $199,599
2016 ADRO 0 $0 100,905 $1,661,727 135,000 $164,699
2015 ADRO 0 $0 51,470 $1,488,810 65,000 $84,799

Yearly summary of insider trading at Onyx Pharmaceuticals Inc (ONXX) by Schafer Gregory W

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2008 ONXX 0 $0 19,561 $750,537 18,000 $291,780
2006 ONXX 2,500 $33,392 0 $0 0 $0

Yearly summary of insider trading at Capricor Therapeutics, Inc. (NILT.OB) by Schafer Gregory W

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2008 NILT.OB 100 $459 0 $0 0 $0


Insider trading activities at 3 companies by Schafer Gregory W:

1. Aduro Biotech, Inc. (ADRO)

2. Onyx Pharmaceuticals Inc (ONXX)

3. Capricor Therapeutics, Inc. (NILT.OB)

Table 1. Insider trading of Aduro Biotech, Inc. (ADRO) by Schafer Gregory W

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2018-01-25 ADRO Option Ex 60,000 .82 49,200
2017-12-29 ADRO Option Ex 42,000 .82 34,440
2018-01-02 ADRO Option Ex 20,000 1.14 22,700
2018-01-02 ADRO Sale 20,000 7.61 152,140
2017-12-01 ADRO Sale 20,000 9.34 186,880
2017-12-01 ADRO Option Ex 20,000 1.14 22,700
2017-11-06 ADRO Sale 20,000 7.97 159,320
2017-11-06 ADRO Option Ex 20,000 1.14 22,700
2017-10-02 ADRO Option Ex 20,000 1.14 22,700
2017-10-02 ADRO Sale 20,000 10.75 215,060
2017-09-13 ADRO Sale 4,859 10.99 53,380
2017-09-01 ADRO Option Ex 20,000 1.23 24,500
2017-09-01 ADRO Sale 20,000 11.70 233,980
2017-08-07 ADRO Option Ex 25,811 1.23 31,618
2017-08-08 ADRO Option Ex 14,189 1.23 17,381
2017-08-07 ADRO Sale 25,811 12.17 314,223
2017-08-08 ADRO Sale 14,189 12.16 172,552
2017-06-28 ADRO Option Ex 40,000 1.45 58,000
2017-06-28 ADRO Sale 40,000 11.26 450,560
2016-12-23 ADRO Option Ex 35,000 .82 28,700
2016-11-10 ADRO Option Ex 49,856 1.45 72,291
2016-11-11 ADRO Option Ex 30,144 1.45 43,708
2016-11-10 ADRO Sale 49,856 14.74 734,678
2016-11-11 ADRO Sale 30,144 14.86 448,030
2016-05-16 ADRO Sale 905 8.20 7,420
2016-01-08 ADRO Sale 20,000 23.58 471,599
2016-01-08 ADRO Option Ex 20,000 1.00 20,000
2015-12-24 ADRO Option Ex 15,000 .82 12,300
2015-12-07 ADRO Option Ex 25,000 1.45 36,250
2015-12-07 ADRO Sale 25,000 29.80 745,125
2015-11-17 ADRO Sale 15,178 28.31 429,689
2015-11-16 ADRO Sale 11,292 27.81 313,996
2015-11-17 ADRO Option Ex 15,178 1.45 22,008
2015-11-16 ADRO Option Ex 9,822 1.45 14,241

Table 2. Insider trading of Onyx Pharmaceuticals Inc (ONXX) by Schafer Gregory W

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2008-09-18 ONXX Option Ex 10,000 16.21 162,100
2008-09-18 ONXX Sale 10,000 40.00 400,000
2008-07-15 ONXX Sale 1,561 37.50 58,537
2008-06-25 ONXX Sale 8,000 36.50 292,000
2008-06-25 ONXX Option Ex 8,000 16.21 129,680
2006-08-11 ONXX Buy 2,500 13.36 33,392

Table 3. Insider trading of Capricor Therapeutics, Inc. (NILT.OB) by Schafer Gregory W

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2008-04-15 NILT.OB Buy 100 4.60 459

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Schafer Gregory W (Director of Aduro Biotech, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.